Simple Plex for COVID-19 Research
Real-Time Biological Phenotyping
When researching an acute SARS-CoV-2 infection and the resulting and deadly COVID-19 disease, speed and data quality are key. Ella enables cytokine and pro-inflammatory biomarker immunoassays in a multianalyte, automated and standardized format. Get the most reliable immunoassay results in real time with Ella.
- After loading the cartridge, data is available in just 75 minutes, getting you to critical decision points faster
- Factory calibrated cartridges and built-in standard curves minimize inter-lot variability allowing you to get the same measurement anywhere
- 80% reduction in manual steps eliminates operator error and inconsistent results
Discount Pricing on Ella for COVID-19 Research
Ella is here to help in your fight against COVID-19. For researchers in this space, we're offering the fully automated platform for 25% off. If you're fighting this terrible disease, then we'd like to help!
How Ella is Helping During COVID-19
Ella is at the forefront of the fight against COVID-19. The Human Immune Monitoring Center at Mount Sinai is leveraging the high-quality data and real-time results of Ella to understand if an immunologic response during COVID-19 is turning deadly. This insight is helping them determine if novel immuno-modulating therapies have the potential to mediate response to the virus.
Watch this virtual meeting organized by the NIH and FDA, to learn more about the role of cytokines in COVID-19 and how researchers at Mount Sinai established a rapid and quantitative cytokine test on Ella to obtain actionable immune monitoring data during the management of COVID-19 patients.
Watch Mount Sinai’s Miriam Merad, M.D., Ph.D. discuss the progress they’ve made using Ella for real-time immune profiling of the hyperinflammatory response during COVID-19 in this webinar.
Researchers at the Ichan School of Medicine at Mount Sinai publish in Nature Medicine using The Cytokine Storm Panel on Ella! Read their work, entitled, “An Inflammatory cytokine signature predicts COVID-19 severity and survival”.
PROFILING HOST RESPONSES IN COVID-19 INFECTIONS: ACCELERATING BIOMARKER RESEARCH WITH ELLA
"A major advantage of Ella is that it’s very easy to use with virtually no maintenance, and it’s really fast. Simply dilute your sample and you’re ready to go—without the need for manual preparations that can take time and add user variability."
- Dr. Jesús F Bermejo-Martín, Principal Investigator, Institute of Biomedical Research of Salamanca (IBSAL)/Hospital Universitario Río Hortega de Valladolid
Ella Promises Better Clinical Care for Acute Respiratory Failure and Sepsis
"Timely results from Ella have the potential to direct treatment for acute diseases where administration needs to take place in a matter of hours."
- Michael Matthay, M.D., Ph.D., Professor of Medicine, University of California San Francisco
Characterizing T-cell Immune Responses Against SARS-CoV-2 with Ella
"Ella is a simple and fast immunoassay platform that would be ideal for implementation in higher biosafety facilities, like BSL-3, to study the acute phase of SARS-CoV-2 infection."
- Anthony Tanoto Tan, Ph.D., Senior Research Fellow, Duke-NUS Medical School, Singapore
COVID-19 Research Publications Using Ella
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 Infection
Nina Le Bert, Hannah E. Clapham, Anthony T. Tan, Wan Ni Chia, Christine Y.L. Tham, Jane M. Lim, Kamini Kunasegaran, Linda Wei Lin Tan, Charles-Antoine Dutertre, Nivedita Shankar, Joey M.E. Lim, Louisa Jin Sun, Marina Zahari, Zaw Myo Tun, Vishakha Kumar, Beng Lee Lim, Siew Hoon Lim, Adeline Chia, Yee-Joo Tan, Paul Anantharajah Tambyah, Shirin Kalimuddin, David Lye, Jenny G.H. Low, Lin-Fa Wang, Wei Yee Wan, Li Yang Hsu, Antonio Bertoletti, and Clarence C. Tam J Exp Med, May 2021
- Cytokine prediction of mortality in COVID19 patients
Mathilda Mandel, Gil Harari, Michael Gurevich, Anat Achiron
Cytokine, June 2020
- An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19
Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, GermanaGrassi, Eleonora Tartaglia, Rita Casetti, Letizia Giancola, Nazario Bevilacqua,Markus Maeurer, Alimuddin Zumla, Franco Locatelli, Fabrizio De Benedetti,Fabrizio Palmieri, Luisa
Clinical Infectious Diseases, May 2020
- Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi, Rita Casetti, Eleonora Tartaglia, Eleonora Lalle, Alessandra D’Abramo, Concetta Castilletti, Luisa Marchioni, Yufang Shi, Andrea Mariano, Jin-Wen Song
Cell Death & Differentiation, June 2020
Simple Plex COVID-19 Cytokine Storm Panel
Measure key inflammation markers that are indicative of pathologic inflammatory response with a high-quality multianalyte assay. The 16x4 COVID-19 Cytokine Storm Panel is perfect for batching small numbers of samples and getting results fast. Learn more about the multianalyte cartridge.
|COVID-19 Cytokine Storm Panel Markers|
|IL-1-beta||IL-6 2nd Gen||IL-8||TNF alpha 2nd Gen|
Simple Plex Cytokine Screening Panel
The 32x8 Multiplex Cytokine Screening Panel gives you deep insight into an immunological response across a spectrum of critical markers. Get up to 256 results in just 90 minutes. Learn more about the multiplex cartridge.
|Cytokine Screening Panel Markers|
|IFN-gamma 3rd Gen||IL-10||IL-2||IL-6 2nd Gen|
|IL-1-beta||IL-12p70||IL-4||TNF alpha 2nd Gen|
In response to the global COVID-19 pandemic, the COVID-19 Cytokine Storm Panel and Multiplex Cytokine Screening Panel are available off the shelf and at a special discount. Off-the-shelf cartridges ship within 48 hours in the continental US.
DISCLAIMER: The Ella™ automated immunoassay platform is currently offered For Research Use Only; Not for Use in Diagnostic Procedures.
Bio-Techne's Tools for Coronavirus Research
As a leading company in the life sciences research sector, Bio-Techne develops products and resources to support coronavirus research, including reagents and platforms for SARS-CoV-2 detection, cytokine monitoring, and drug discovery. These tools help the scientific community better understand the mechanisms of infection and develop effective treatments. Learn more about Bio-Techne's portfolio or products for Coronavirus Research.